Please log in to watch this conference skillscast.
The goal was to detect if there was something in the gene mapping of patients which could tell researchers and healthcare professionals how the patient will react to the treatment. In this way, they can prevent sending patients to a very intensive type of treatment (which can lead to numerous negative long-term side effects), if they know the patients are likely to react well to lower-intensity treatment.
YOU MAY ALSO LIKE:
Mostly Harmless' Machine Learning: Use Case from Healthcare from a Banking Hackathon
Violeta has been working as a data scientist in the Data Innovation and Analytics department in ABN AMRO bank located in Amsterdam, the Netherlands.